Back

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells

Hughes, S. M.; Levy, C. N.; Chamberlain, D. R.; Varon, D.; Murphy, B.; Schwedhelm, K.; Lund, J. M.; Prlic, M.; De Rosa, S. C.; Micks, E.; Johnston, C.; Hladik, F.

2026-05-19 immunology
10.64898/2026.05.15.725524 bioRxiv
Show abstract

ProblemThe anti-microbial protein granulysin is present in vaginal secretions during the follicular phase of the menstrual cycle but nearly disappears during the luteal phase. The reason for this change is unknown. Method of studyParticipants (n = 23) with regular menstrual cycles collected daily vaginal swabs for granulysin ELISAs. Endocervical cytobrushes, ectocervical biopsies, vaginal biopsies, and PBMC were collected across the cycle to enumerate granulysin-expressing cells by flow cytometry. Cycle phase was determined by daily urinary luteinizing hormone testing and confirmed by serum progesterone levels. ResultsGranulysin levels in secretions were up to 10,000 times higher during menstruation than during the luteal phase (menstruation, median 3,924 pg/mL [IQR 400-17,280]; luteal, median and IQR undetectable [<7.81 pg/mL]). In the endocervical canal, granulysin-expressing cells were much more abundant during menstruation than during the mid-follicular or mid-luteal phases. In contrast, the number of granulysin-expressing cells in the ectocervix and vagina remained stable during the cycle. The most abundant granulysin-expressing cell types in the mucosa were CD8 T cells and NK cells. In a minority of participants, granulysin was consistently detected in luteal-phase swabs; this phenomenon was associated with parity. ConclusionsGranulysin in vaginal secretions is associated with menstruation, which also drives a spike in granulysin-expressing cells in the endocervical canal. This result explains the much higher granulysin levels in secretions during the follicular than the luteal phase. In contrast, immune cells from ectocervical and vaginal biopsies express granulysin independently of the menstrual cycle, indicating their continuous ability to respond to microbial infection.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
The Journal of Infectious Diseases
182 papers in training set
Top 0.1%
18.8%
2
Frontiers in Immunology
586 papers in training set
Top 0.6%
10.2%
3
BMC Medicine
163 papers in training set
Top 0.2%
10.2%
4
PLOS ONE
4510 papers in training set
Top 31%
4.9%
5
Scientific Reports
3102 papers in training set
Top 23%
4.9%
6
The Journal of Immunology
146 papers in training set
Top 0.4%
3.6%
50% of probability mass above
7
Brain, Behavior, and Immunity
105 papers in training set
Top 0.7%
3.1%
8
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 2%
2.1%
9
Nature Communications
4913 papers in training set
Top 49%
1.9%
10
Mucosal Immunology
42 papers in training set
Top 0.1%
1.8%
11
eLife
5422 papers in training set
Top 41%
1.7%
12
Cell Reports
1338 papers in training set
Top 24%
1.7%
13
Immunology
29 papers in training set
Top 0.4%
1.7%
14
mSphere
281 papers in training set
Top 4%
1.5%
15
Cell Communication and Signaling
35 papers in training set
Top 0.6%
1.3%
16
iScience
1063 papers in training set
Top 21%
1.2%
17
mSystems
361 papers in training set
Top 6%
1.0%
18
Frontiers in Physiology
93 papers in training set
Top 5%
0.9%
19
eBioMedicine
130 papers in training set
Top 4%
0.8%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 44%
0.8%
21
PLOS Biology
408 papers in training set
Top 19%
0.8%
22
Open Research Europe
14 papers in training set
Top 0.2%
0.7%
23
The FASEB Journal
175 papers in training set
Top 3%
0.7%
24
Immunology & Cell Biology
11 papers in training set
Top 0.4%
0.6%
25
Infection and Immunity
103 papers in training set
Top 0.8%
0.6%
26
Journal of Leukocyte Biology
40 papers in training set
Top 0.5%
0.6%
27
Endocrinology
38 papers in training set
Top 0.7%
0.6%
28
BMC Infectious Diseases
118 papers in training set
Top 6%
0.6%
29
Science Advances
1098 papers in training set
Top 33%
0.6%
30
Cell Reports Medicine
140 papers in training set
Top 9%
0.6%